Get complete Patent Opposition Report for Biogen Idec Ma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Biogen Idec Ma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2645106Oct 2, 2024Methods And Products For Evaluating An Immune Response To A Therapeutic Agent1
EP2701778Oct 18, 2023A Limiter For A Dispensing Device2
EP2653873Aug 24, 2022Compositions And Uses For Treating Multiple Sclerosis14
EP2870250Jun 29, 2022Cell Line Expressing Single Chain Factor Viii Polypeptides And Uses Thereof2
EP2676967Aug 14, 2019Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab1
EP2715352Apr 24, 2019Method Of Assessing Risk Of Pml1
EP2483289Mar 20, 2019Methods Of Preventing And Removing Trisulfide Bonds3
EP2707383Apr 18, 2018Methods Of Preventing And Removing Trisulfide Bonds2
EP1991267Dec 20, 2017Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab1
EP2524060Nov 29, 2017Assay For Jc Virus Antibodies1